Study lung cancer samples to understand relapse resistance
Part of Cancer, Lungs & breathing clinical trials.
This trial looks at information and tissue from people with stage I to stage IIIA non-small cell lung cancer (NSCLC) who have surgery, sometimes with chemotherapy before surgery. Researchers want to understand why cancers come back (resistance) and how to better target treatments later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage I, stage II, or stage IIIA non-small cell lung cancer (NSCLC)
- You had surgery to remove the cancer (resection)
- Your treatment may include chemotherapy before surgery (neoadjuvant) or not
- You can provide details like age/demographics and smoking history
- You have medical records with pre-surgery information and follow-up, including relapse and later treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with stage I lung cancer to see how they do after surgery. It aims to learn what affects recovery and long-term outcomes.
This study tests a new way to predict if non-small cell lung cancer will return after surgery. You will give blood samples to look for cancer cells, and the team will build a model to help plan better follow-up care.
This study follows people with lung cancer over time to see how the disease changes, especially during and after treatment. By collecting tumor samples and blood tests every few months, researchers hope to understand why some cancers come back or become resistant, and find better ways to treat them.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at how lung cancer changes over time by analyzing tumor tissue and blood. It may help researchers understand what drives cancer relapse after early-stage surgery.
This study is for people with non-small cell lung cancer who can have curative treatment. It looks for tiny bits of cancer DNA in blood after treatment to see if it helps predict if the cancer comes back. It tests how often to check for this DNA.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.